Major Clinical Study Using Semler's QuantaFlo® for Medicare Advantage Beneficiaries, Demonstrates that National, In-Home Screening for Peripheral Artery Disease (PAD) is Feasible

/PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of...

Related Keywords

Puerto Rico ,United States ,Susana Noonan ,Optum Housecalls ,American College Of Preventive Medicine ,Drug Administration ,Sa Noonan Communications ,Association For Prevention Teaching ,Nasdaq ,Mellitus Health ,Exchange Commission ,Semler Scientific Inc ,Semler Scientific ,American College ,Preventive Medicine ,Prevention Teaching ,Artery Disease Screening ,Year Mortality ,Cardiovascular Events ,Adverse Limb Events ,Medicare Advantage ,About Semler Scientific ,Insulin Insights ,Monarch Medical Technologies ,Nc ,